Johnson & Johnson's Near Term Growth Likely To Remain Subdued

Johnson & Johnson will report its Q2 2017 earnings on July 18. The company's pharmaceutical business disappointed investors in the first quarter as growth stalled due to pricing issues and competitive pressure.